ImportRefusal LogoImportRefusal

International Pharmaceuticals, Inc.

⚠️ Moderate Risk

FEI: 3004679500 • Kasambagan, Cebu • PHILIPPINES

FEI

FEI Number

3004679500

📍

Location

Kasambagan, Cebu

🇵🇭
🏢

Address

Pope John Paul Ii Avenue, 3 Golam Drive, Kasambagan, Cebu, Philippines

Moderate Risk

FDA Import Risk Assessment

42.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

13
Total Refusals
6
Unique Violations
10/29/2021
Latest Refusal
3/17/2004
Earliest Refusal

Score Breakdown

Violation Severity
70.5×40%
Refusal Volume
42.5×30%
Recency
1.8×20%
Frequency
7.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

758×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1186×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

162×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

4831×

DRUG NAME

The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.

721×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

Refusal History

DateProductViolationsDivision
10/29/2021
62MAL01CAMPHOR (ANTI-PRURITIC)
118NOT LISTED
3280FRNMFGREG
Division of Southeast Imports (DSEI)
7/3/2018
66VRE99MISCELLANEOUS PATENT MEDICINES, ETC.
72NEW VET DR
Division of Southeast Imports (DSEI)
4/26/2013
66YBK99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
75UNAPPROVED
Los Angeles District Office (LOS-DO)
4/26/2013
62MBL01CAMPHOR (ANTI-PRURITIC)
75UNAPPROVED
Los Angeles District Office (LOS-DO)
4/26/2013
62MBL01CAMPHOR (ANTI-PRURITIC)
483DRUG NAME
75UNAPPROVED
Los Angeles District Office (LOS-DO)
2/5/2013
53LD03FACE,BODY,AND HAND (EXCLUDING SHAVING PREPARATIONS) (SKIN CARE PREPARATIONS)
75UNAPPROVED
Los Angeles District Office (LOS-DO)
2/5/2013
53BD01BATH OILS, TABLETS AND SALTS (BATH PREPARATIONS)
75UNAPPROVED
Los Angeles District Office (LOS-DO)
12/7/2012
66VCL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
San Francisco District Office (SAN-DO)
12/7/2012
62HAL99ANTI-MICROBIAL N.E.C.
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
San Francisco District Office (SAN-DO)
10/14/2008
62QBL08SALICYLATE MEGLUMINE (ANTI-RHEUMATIC)
75UNAPPROVED
Florida District Office (FLA-DO)
9/1/2005
61XAA05CARBINOXAMINE MALEATE (ANTI-HISTAMINIC)
118NOT LISTED
New Orleans District Office (NOL-DO)
5/3/2005
56YYY99ANTIBIOTIC N.E.C.
118NOT LISTED
San Francisco District Office (SAN-DO)
3/17/2004
66YBK99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
118NOT LISTED
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is International Pharmaceuticals, Inc.'s FDA import refusal history?

International Pharmaceuticals, Inc. (FEI: 3004679500) has 13 FDA import refusal record(s) in our database, spanning from 3/17/2004 to 10/29/2021.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. International Pharmaceuticals, Inc.'s FEI number is 3004679500.

What types of violations has International Pharmaceuticals, Inc. received?

International Pharmaceuticals, Inc. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about International Pharmaceuticals, Inc. come from?

All FDA import refusal data for International Pharmaceuticals, Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.